PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
PVLA
41 hedge funds and large institutions have $143M invested in Palvella Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+8
Holders Change %
+24.24%
% of All Funds
0.56%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
15
Increased
9
Reduced
4
Closed
7
Calls
$56K
Puts
$2K
Net Calls
+$54K
Net Calls Change
+$54K
Top Buyers
1 |
Millennium Management
New York
|
+$7.55M |
2 |
WP
Woodline Partners
San Francisco,
California
|
+$5.43M |
3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$4.82M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.56M |
5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.2M |